Exact Sciences (EXAS) Growth Rates Comparisons to Medical Laboratories Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Exact Sciences Corporation  (NASDAQ: EXAS)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Exact Sciences Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EXAS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) 23.12 % 8.13 % 8.07 % 9.17 %
Q / Q Revenue Growth (Q4 MRQ) 3.35 % 25.31 % 1.81 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q4 TTM) 16.38 % 6.49 % 6.99 % %
Sequential Revenue Growth (for 12 months ending Q4 TTM) 5.36 % 1.94 % 3.47 % 2.08 %
Revenue 5 Year Average Growth 29.95 % 13.12 % 9.34 % 10.71 %


EXAS's Growth Comparisons in IV. Quarter 2025




With 23.12% year on year Revenue increase in the fourth quarter 2025, Exact Sciences outperformed the 8.13% growth in the Medical Laboratories industry, and 8.07% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Medical Laboratories industry, Exact Sciences Corporation reported above average market Sales growth.

Comparing the company's Revenue to the third quarter results, sales were higher by 3.35% . On the yearly basis, average annual sales growth for Exact Sciences is 29.95%, while S & P 500's including only Businesses with the fourth quarter 2025 earnings, average annual sales growth is 10.71% over the past five years.

EXAS Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Screening
22.27 %
6.01 %
Screening Medicare Parts B C
22.8 %
9.02 %
Screening Commercial
22.52 %
4.54 %
Screening Other
18.91 %
3.05 %
Precision Oncology
12.67 %
1.04 %
Precision Oncology Medicare Parts B C
8.16 %
6.98 %
Precision Oncology Commercial
5.64 %
4.88 %
Precision Oncology International
18.92 %
6.38 %
Precision Oncology Other
24.85 %
-23.02 %
United States
20.13 %
4.78 %
Outside of United States
18.92 %
6.38 %
Total
18.01 %
4.87 %


Growth Rates of EXAS's Income in the fourth quarter 2025


EXAS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - 3.74 % 27.58 % 29.95 %
Sequential Operating Income Change (Q4 MRQ) - -7.28 % -17.34 % 4.5 %
Y / Y Operating Income Growth (Q4 TTM) - 66.69 % 36.91 % 14.37 %
Sequential Operating Income Growth (Q4 TTM) - 14.2 % 9.69 % 6.96 %
Operating Income 5 Year Avg. Change - 6.34 % 10.62 % 19.3 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - -74.8 % - 21.83 %
Sequential Income from Cont. Ops. Change (Q4 MRQ) - -27.4 % - 11.13 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - -39.17 % -24.72 % 16.46 %
Sequential Income from Cont. Ops. Change (Q4 TTM) - -24.57 % -5.86 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change - 5.07 % 8.95 % -28.62 %

EXAS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - 46.12 % 16.68 % 21.56 %
Q / Q Net Income Growth (Q4 MRQ) - -27.26 % -34.6 % 11.12 %
Y / Y Net Income Change (Q4 TTM) - 13.19 % 32.85 % 16.59 %
Sequential Net Income Change (Q4 TTM) - 72.76 % 7.36 % 6.03 %
Net Income 5 Year Avg. Growth - 5.34 % 9.41 % 23.12 %

EXAS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - -75.82 % - 21.83 %
Sequential EPS from Cont. Ops. Change (Q4 MRQ) - -27.3 % - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q4 TTM) - - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth - -8.23 % 8.95 % -28.62 %



EXAS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - 40.22 % 16.68 % -28.62 %
Q / Q EPS Net Growth (Q4 MRQ) - -27.16 % -34.6 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q4 TTM) - - - -99.87 %
EPS Net 5 Year Avg. Change - 5.34 % 9.41 % 23.12 %



Exact Sciences reported bottom-line of $ -0.46 in the fourth quarter, compare to $ -4.69 in the same quarter a year ago. Medical Laboratories industry grew by 40.22%, while Healthcare sector increased by 16.68%, and overall market improved by 21.56%.

Comparing company's EPS to the third quarter results, income per share were higher by 3.35% . On the yearly basis, average annual income per share growth for Exact Sciences is 29.95%, while S & P 500's including only the businesses with the fourth quarter 2025 Results, average annual income per share growth is 23.12% over the past five years.

EXAS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) 213.83 % -25.07 % -10.42 % 2 %
Sequential Free Cash Flow Change (Q4 MRQ) -36.62 % -8.23 % -28.82 % 22.32 %
Y / Y Free Cash Flow Change (Q4 TTM) 523.97 % 24.63 % 10.95 % 11.81 %
Sequential Free Cash Flow Change (Q4 TTM) 29.87 % -0.08 % 1.77 % 2.41 %
Free Cash Flow 5 Year Avg. Change - 10.39 % 2.66 % 12.12 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) 1294.93 % - -90.24 % 1035.72 %
Sequential Net Cash Flow Change (Q4 MRQ) 26.54 % 28.43 % -99.01 % -
Y / Y Net Cash Flow Change (Q4 TTM) - 856.37 % -25.5 % -
Sequential Net Cash Flow Change (Q4 TTM) - - -27.24 % -
Net Cash Flow 5 Year Avg. Change 82.84 % -9.51 % 6.46 % 1.12 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 259.78 % 24.59 % 9.45 % 23.41 %
Sequential Capital Expenditures Change (Q4 MRQ) 4.5 % 41.29 % 18.78 % 18.97 %
Y / Y Capital Expenditures Change (Q4 TTM) -12.19 % 30.26 % 11.09 % 23.88 %
Sequential Capital Expenditures Change (Q4 TTM) 20.12 % 28.46 % 6.99 % 7.02 %
Capital Expenditures 5 Year Avg. Change -4.76 % 5.31 % 8.45 % 13.11 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.